Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

53 Stocks Moving In Thursday's Mid-Day Session

Published 02/06/2022, 17:17
Updated 02/06/2022, 18:10
© Reuters.  53 Stocks Moving In Thursday's Mid-Day Session

© Reuters. 53 Stocks Moving In Thursday's Mid-Day Session

Gainers

  • Repare Therapeutics Inc. (NASDAQ: RPTX) jumped 38.1% to $12.08 after the company announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib. Repare will receive a $125 million upfront payment and is eligible to receive up to an additional $1.2 billion in potential milestones.
  • Redbox Entertainment Inc. (NASDAQ: RDBX) rose 28.1% to $7.18 after declining over 16% on Wednesday.
  • Yumanity Therapeutics, Inc. (NASDAQ: YMTX) gained 25.3% to $1.4288. Yumanity Therapeutics, last month, posted a Q1 loss of $1.24 per share.
  • Avaya Holdings Corp. (NYSE: AVYA) jumped 24.4% to $5.30.
  • MDJM Ltd (NASDAQ: MDJH) gained 24.2% to $2.0494.
  • Immix Biopharma, Inc. (NASDAQ: IMMX) rose 24.1% to $2.2950 after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
  • American Superconductor Corporation (NASDAQ: AMSC) gained 23.8% to $6.54 following Q4 results.
  • Missfresh Limited (NASDAQ: MF) rose 21.6% to $0.2978 after gaining over 51% on Wednesday.
  • electroCore, Inc. (NASDAQ: ECOR) gained 20.4% to $0.6204.
  • Credo Technology Group Holding Ltd (NASDAQ: CRDO) gained 20% to $12.30 after the company reported Q4 EPS results up from last year and better-than-expected sales results. The company also issued Q1 sales guidance above analyst estimates.
  • PyroGenesis Canada Inc. (NASDAQ: PYR) jumped 18.8% to $3.04. PyroGenesis announced project to introduce plasma torches into the upstream anode baking process.
  • Pure Storage, Inc. (NYSE: PSTG) shares climbed 18.6% to $28.48 after the company reported better-than-expected Q1 financials results. The company also issued Q2 and FY23 sales guidance above analyst estimates.
  • Chewy, Inc. (NYSE: CHWY) rose 18.5% to $27.85 after the company reported better-than-expected Q1 sales results.
  • Uranium Energy Corp. (NYSE: UEC) gained 17.6% to $4.1750.
  • MongoDB, Inc. (NASDAQ: MDB) rose 17.4% to $284.11 after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
  • Rain Therapeutics Inc. (NASDAQ: RAIN) jumped 17.2% to $2.86. Roth Capital initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $16.
  • Dunxin Financial Holdings Limited (NYSE: DXF) rose 17.2% to $0.58.
  • RISE Education Cayman Ltd (NASDAQ: REDU) gained 17.1% to $1.64.
  • Integrated Media Technology Limited (NASDAQ: IMTE) jumped 17% to $9.39.
  • UiPath Inc. (NYSE: PATH) shares rose 16.1% to $19.54 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
  • Gevo, Inc. (NASDAQ: GEVO) gained 15.8% to $4.7401. Gevo, last month, reported better-than-expected Q1 sales results.
  • MicroVision, Inc. (NASDAQ: MVIS) jumped 15.6% to $3.9650.
  • Elastic N.V. (NYSE: ESTC) rose 15.4% to $71.50 after the company reported better-than-expected Q4 EPS and sales results.
  • KE Holdings Inc. (NYSE: BEKE) gained 15.1% to $14.58. KE Holdings recently announced better-than-expected Q1 sales results.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) surged 14.9% to $1.3101.
  • Lands' End, Inc. (NASDAQ: LE) jumped 14.7% to $12.78 after the company reported better-than-expected Q1 EPS results.
  • Pineapple Energy Inc. (NASDAQ: PEGY) jumped 14.4% to $2.39.
  • Veeva Systems Inc. (NYSE: VEEV) surged 14% to $191.36 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY22 EPS guidance above analysts estimates.
  • comScore, Inc. (NASDAQ: SCOR) gained 13.9% to $2.21. comScore Director Paul William Livek acquired a total of 600,000 shares at an average price of $1.92.
  • Bright Green Corporation (NASDAQ: BGXX) gained 13.3% to $4.0101 after dropping 30% on Wednesday.
  • Blue Apron Holdings, Inc. (NYSE: APRN) rose 9.7% to $3.3663 after the company announced it will be offering a selection of meal kits without a subscription on Walmart (NYSE:WMT).com.
Losers
  • Zosano Pharma Corporation (NASDAQ: ZSAN) fell 47.4% to $0.9250 after the company announced it filed a voluntary petition for relief under chapter 11.
  • Immunic, Inc. (NASDAQ: IMUX) shares dipped 41.2% to $3.47 after the company reported data from its Phase 2 CALDOSE-1 trial of Vidofludimus Calcium did not achieve the primary endpoint.
  • Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) dropped 40.1% to $0.8983. Aeglea BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter.
  • Centessa Pharmaceuticals plc (NASDAQ: CNTA) fell 20% to $3.60 after the company announced it has made a strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease including both the Phase 3 ACTION study and the open-label ALERT study.
  • WiSA Technologies, Inc. (NASDAQ: WISA) declined 19.4% to $0.6456.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) fell 17% to $3.3740 following effect of 1:10 reverse stock split.
  • CN Energy Group. Inc. (NASDAQ: CNEY) dropped 15.6% to $1.73.
  • Innovid Corp. (NYSE: CTV) fell 15.4% to $2.9950.
  • Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) shares declined 14.9% to $4.56 after the company priced its common stock offering of 10 million shares at $4.75 per share.
  • Midatech Pharma plc (NASDAQ: MTP) dropped 14.7% to $0.64. The U.S. Food and Drug Administration (FDA) recently granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ: MTP) lead drug candidate MTX110 for the treatment of patients with recurrent glioblastoma (rGBM).
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) fell 14.6% to $0.38.
  • Limelight Networks, Inc. (NASDAQ: LLNW) declined 13.9% to $2.9950.
  • Energy Focus, Inc. (NASDAQ: EFOI) fell 13.5% to $1.0550 after jumping 37% on Wednesday.
  • Lightwave Logic, Inc. (NASDAQ: LWLG) dropped 12.4% to $6.95.
  • Mullen Automotive, Inc. (NASDAQ: MULN) fell 11.5% to $1.2550. Mullen Automotive recently announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana.
  • Advanced Human Imaging Limited (NASDAQ: AHI) dropped 11.1% to $0.7225.
  • Histogen Inc. (NASDAQ: HSTO) shares fell 10.7% to $0.14. Histogen reported a 1-for-20 reverse stock split.
  • Nutex Health, Inc. (NASDAQ: NUTX) fell 10.5% to $9.64.
  • Enjoy Technology, Inc. (NASDAQ: ENJY) dropped 10.2% to $0.2563.
  • C3.ai, Inc. (NYSE: AI) shares fell 9.8% to $16.73 after the company issued Q1 and FY23 sales guidance below analyst estimates.
  • Conn's, Inc. (NASDAQ: CONN) dropped 9.2% to $11.38. The company reported mixed results for its first quarter.
  • Hewlett Packard Enterprise Company (NYSE: HPE) fell 6.6% to $14.75 after the company reported worse-than-expected Q2 financials results. The company also issued Q3 and FY22 EPS guidance with midpoints below analyst estimates.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.